We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
NPCE

Price
10.79
Stock movement up
+0.36 (3.45%)
Company name
Neuropace Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Medical Devices
Market cap
322.06M
Ent value
393.12M
Price/Sales
4.21
Price/Book
32.79
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-23.15%
3 year return
8.92%
5 year return
-
10 year return
-
Last updated: 2025-04-18

DIVIDENDS

NPCE does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales4.21
Price to Book32.79
EV to Sales5.14

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count29.85M
EPS (TTM)-0.95
FCF per share (TTM)-0.57

Income statement

Loading...
Income statement data
Revenue (TTM)76.45M
Gross profit (TTM)56.44M
Operating income (TTM)-23.07M
Net income (TTM)-28.09M
EPS (TTM)-0.95
EPS (1y forward)-0.91

Margins

Loading...
Margins data
Gross margin (TTM)73.83%
Operating margin (TTM)-30.17%
Profit margin (TTM)-36.74%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash15.42M
Net receivables11.56M
Total current assets82.59M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets96.30M
Accounts payable2.16M
Short/Current long term debt73.50M
Total current liabilities14.78M
Total liabilities86.48M
Shareholder's equity9.82M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-16.49M
Capital expenditures (TTM)299.00K
Free cash flow (TTM)-16.79M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-285.97%
Return on Assets-29.17%
Return on Invested Capital-209.28%
Cash Return on Invested Capital-125.10%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open10.42
Daily high10.95
Daily low10.25
Daily Volume173K
All-time high26.50
1y analyst estimate15.33
Beta1.80
EPS (TTM)-0.95
Dividend per share-
Ex-div date-
Next earnings date6 Jun 2025

Downside potential

Loading...
Downside potential data
NPCES&P500
Current price drop from All-time high-59.28%-14.12%
Highest price drop-95.13%-56.47%
Date of highest drop28 Dec 20229 Mar 2009
Avg drop from high-64.21%-11.07%
Avg time to new high334 days12 days
Max time to new high1000 days1805 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
NPCE (Neuropace Inc) company logo
Marketcap
322.06M
Marketcap category
Small-cap
Description
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
Employees
184
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
No events found

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...